IL2 and neoplasm: HPK1 KO T cells were demonstrated to be resistant to PGE2-mediated suppression of T-cell proliferation, IL-2 production, and apoptosis, suggesting that PGE2 utilizes HPK1, at least in part, to suppress T cell-mediated anti-tumor responses [16].